The "rave" phenomenon—loud music, flashing lights, and frenzied all-night dancing—has been a major element in the resurgence of psychedelic drug use in Western society.1 Purportedly central to raves is the use of "club drugs," including 3,4-methylenedioxy-methamphetamine, also called MDMA or ecstasy.1 The use of ecstasy seems to be increasing worldwide, with rave attendees being a high-risk population. Because these drugs have potentially serious physical and psychological consequences, such as anxiety, memory loss, paranoia, depression, cognitive impairment, cardiac complications, and kidney failure,2,3 the rave phenomenon has sparked the attention of health officials and policy makers. However, to our knowledge, no studies have collected self-report or objective drug use information from rave attendees in the United States.
Ecstasy use according to self-report and saliva analysis among club rave attendees (N = 96). Asterisk indicates that saliva analysis is useful for the detection of ecstasy only within 48 hours of use.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 47
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.